Publications

5532 Results

Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma: A Southwest Oncology Group study.

Authors
WS Fletcher;DS Daniels;VK Sondak;B Dana;R Townsend;HE Hynes;LF Hutchins;JR Pancoast
Journal / Conference
AJCO 16(4):359-362
Year
1993
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8804

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Authors
MM Zalupski;J Benedetti;SP Balcerzak;LF Hutchins;RJ Belt;A Hantel;JW Goodwin
Journal / Conference
IND 11:337-341
Year
1993
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8930

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group trial.

Authors
SA Taylor;J Benedetti;D Schuller;SP Richman;GO Broun;A Hantel
Journal / Conference
IND 11:227-229
Year
1993
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8932

A phase II trial of piroxantrone in adenocarcinoma of the pancreas: A Southwest Oncology Group study.

Authors
TR Jenkins;C Tangen;JS Macdonald;G Weiss;R Chapman;A Hantel
Journal / Conference
IND 11:329-331
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8933

A phase II study of external beam radiation and chemotherapy with cisplatin/BCNU followed by BCNU alone of the treatment of incompletely resected high grade brain tumors: Preliminary results of a Southwest Oncology Group (SWOG) study (SWOG-9016).

Authors
S Petersdorf;C Upchurch;H Eyre;J Townsend;B Griffin;R Livingston;A Spence;M Berger
Journal / Conference
ASCO 12:176(#501)
Year
1993
Research Committee(s)
Brain
Study Number(s)
SWOG-9016

In the era of prostate specific antigen (PSA), is prostate acid phosphatase (PAP) necessary for staging prostate cancer? A Southwest Oncology Group study.

Authors
IM Thompson;EJ Zeidman;ED Crawford;AI Sagalowski;PF Schellhammer;RW deVere White;HB Grossman;E Klein;BA Lowe;AJ Bueschen;PT Scardino;RC Flanigan
Journal / Conference
American Urological Association Inc. 149:308A(#360)
Year
1993

Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwest Oncology Group.

Authors
TP Miller;S Dahlberg
Journal / Conference
Malignant Lymphomas Including Hodgkins Disease 4:53-63
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

Authors
EV Hannigan;S Green;DS Alberts;R O'Toole;E Surwit
Journal / Conference
Oncology 50(Suppl.2):2-9
Year
1993
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

NCAM (CD56)-positive malignant lymphoma.

Authors
WF Kern;CM Spier;TP Miller;TM Grogan
Journal / Conference
Leukemia & Lymphoma 12:1-10
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22).

Authors
JR Downing;DR Head;AM Curcio-Brint;MG Hulshof;TA Motroni;SC Raimondi;AJ Carroll;HA Drabkin;CL Willman;KS Theil;CI Civin;P Erikson
Journal / Conference
Blood 81(11):2860-2865
Year
1993
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)